[Update 5.30PM 2015-03-26: Wiley have now ‘freed’ the wrongly-paywalled articles in response to this. It doesn’t change the fact that these articles were wrongly on sale for 2 months and 26 days. They have also wrongly sold access to these articles.]
Wiley are currently (3PM 2015-03-26) charging for access to thousands of articles that should be free to access.
They have recently (legitimately) taken control of a journal called Limnology and Oceanography from the Association for the Sciences of Limnology and Oceanography (ASLO). The association makes clear in its guidelines for the journal that all articles are placed into Free Access after three years (source).
Yet today, I see that Wiley is selling access to articles from Limnology and Oceanography for $45.60 USD (inc. tax). I know this because I bought access to an article myself. Screenshot at the bottom. In fact volumes 41 (1996) to 1 (1956), consisting of thousands of articles are currently on sale at Wiley.
How many times has Wiley sold access to articles from this journal that are greater than three years old: i.e. articles that should be free to read?
Did the Association for the Sciences of Limnology and Oceanography (ASLO) give them permission to sell access to articles that are more than three years old?
What do the authors think about access to their work being sold for $45.60 per article?
What do society members of the Association for the Sciences of Limnology and Oceanography (ASLO) think about this?
Will the society get fiscal compensation for this mishandling of their material?
Is this acceptable? IMO, I think not. IMO it is outrageous that Wiley are selling access to thousands of articles that should be freely available. There should be a full and open investigation into this. Relevant organisations like OASPA and UKSG should step in here. This cannot keep happening.
The authors have gathered some really fascinating data measuring day-by-day altmetrics of papers at the journal Nature Communications, which at the time was hybrid: some articles behind a paywall, some articles were paid-for open access at a cost of $5200 to the authors/funders. (The cost of open access here is an absolute rip-off. I do not endorse or recommend outrageously priced paid-for open access outlets like Nature Communications. PLOS ONE costs just $1350 remember! PeerJ is just $99 per author!)
The paper is by no means perfect – I’m not saying it is – but the ideas behind it are good. Many on twitter have commented that it’s ironic that this paper on open access advantage is itself only made available behind a paywall at the publisher.
The good news is, Dr Xianwen Wang has responded to this and has made an ‘eprint’ copy (stripped of all publisher branding) freely available at arXiv as of 2015-03-19 (post-publication). The written English throughout the manuscript is not brilliant but I feel this reflects poorly on the journal rather than the authors – it’s remarkable that Scientometrics can charge a subscription fee to subscribers if they offer no copy-editing on accepted manuscripts! Finally, technical detail on precisely how the data was obtained is rather lacking. So that’s the critique out of the way…
My tweets about this paper have been very popular e.g.
But I wanted to dig deeper into the data. So I emailed the corresponding author; Xianwen for a copy of the data behind figure 2 and he happily and quickly sent it to me. I was fairly shocked (in a good way) that he sent the data. Most of the times I’ve sent email requests for data in the past have been ultimately unsuccessful. This is well documented in the field of phylogenetics *sad face*. The ‘email the author’ system simply cannot be relied upon, and is one of many reasons why I feel all non-sensitive data supporting research should be made publicly available, alongside the article, on the day of publication.
Xianwen had filtered these suspicious jumps out of his figures but neglected to mention that in the methods section, so upon informing him of this discrepancy he’s told me he’s going to contact the editor to sort it out. A great little example of how data sharing results in improved science? The unfiltered data looks a little bit like the plot below:
Anyway, back to the spikes/jumps in activity – they certainly aren’t an error introduced by the authors of the paper – they can also be seen via Altmetric (a service provider of altmetrics). The question is: what is causing these one-day spikes in activity?
I have alerted the team at Altmetric, and they have/will alert Nature Publishing Group to investigate further
Most of the spikes are likely to be accidental in cause but it would be good to know more. A downloading script gone awry? But there is still a possibility that within this dataset there is putative evidence for deliberate gaming of altmetrics, specifically: article views. I look forward to hearing more from Altmetric and Nature Publishing Group about this… the ball is very much in their court right now.
Moreover, now that these peculiar spikes have been detected; what, if anything, should be done about it?
This is incredibly annoying – they are literally forcing us to use Readcube. That is not cool.
Some will rush to the defence of Readcube and point out that if they detect you have the rights to, you can download the PDF from within Readcube, but that’s missing the point. No-one need waste their precious time whilst Readcube takes ages to load in your browser tab, when all you wanted in the first place was the PDF.
It doesn’t even render the figure images properly, sometimes missing important bits e.g. this figure (below):
Install the add-on called YesScript and ‘blacklist’ all Readcube-tainted websites.
Google Chrome / Chromium users
A) Click the menu button in the top right hand corner of your browser
B) Select Settings
C) (scroll to bottom) Click Show advanced settings
D) Underneath the “Privacy” section, click the “Content settings” button.
Internet Explorer users
I’m tempted to say: install Chrome or Firefox but I’m well aware that some unfortunate academics have ‘university-managed’ computers on which they can’t easily install things. If so try the instructions for IE here. Let me know if you have better solutions for unfortunate IE users.
Added bonus function – extra privacy!
Above all I think we should #BlockReadcube not just for our own utility (easier access to the real PDF), but to send them a powerful message: we do not want the literature to be assimilated and enclosed in rights-restrictions by new technology. We do not want non-consenting ‘cubification of the research literature. We are Starfleet, and as far as I’m concerned: Readcube is the Borg.
PS If you like some of the features of Readcube, try Utopia Docs – it’s free and it’s released under an Open Source license, and it doesn’t force you to use it!
Update 2015-03-20: This post does not indicate I’m suddenly ‘in favour’ of PDF’s by the way, as some seem to have interpreted. If Wiley wanted to do something good, they should publish their full text XML on site like other good publishers do e.g. PLOS, eLife, Hindawi, MDPI, Pensoft, BMC, Copernicus… If they did this then readers could choose to use innovative open source viewing software such the eLife Lens. That kind of change would add value & choice, rather than subtract value (& rights) as they have in this case.
Further discussion of Readcube and rights-restrictions:
Last Friday, I genuinely thought Elsevier had illegally sold me an article that should have been open access. This post is to update you all on what we’ve found out since:
The Scale of the Problem
No one really knows how many articles are wrongly paywalled at all of Elsevier’s various different sales websites. So far, Alicia Wise (Elsevier’s Director of ‘Universal Access’) has admitted that 27 articles were wrongly paywalled in this latest incident and that “a handful” of these were sold to readers for $31.50 per article (source).
This wrong paywalling of paid-for ‘open access’ content also happened in 2014. I have a feeling it will happen in 2016 too…
Do we have the time and resources to keep checking all articles, at all providers of ‘hybrid OA’, to see if they are wrongly or illegally on sale?
Can we trust publishers of ‘hybrid OA’ to keep those paid-for articles outside the paywall, in perpetuity?
A lot of credit for unveiling this latest incident should be given to Marlène Delhaye, whom to my knowledge was the first person to uncover this latest round of problems at Elsevier.
Duration of Imprisonment
If one assumes that these 27 falsely paywalled articles were all from the transfer of the journal Clinical Microbiology and Infection from Wiley to Elsevier, which happened on January 1st, 2015, then we can perhaps assume that these articles were wrongly paywalled for a duration of 2 months and 9 days.
How many readers did these articles lose in that duration because the prospective readers could not get cost-free access to the full text from Elsevier’s websites? Most publisher websites track failed access attempts. For example JSTOR memorably admitted it turned away 150 million people attempting to read paywalled articles in one year.
I have been promised reimbursement for my purchases of articles that should never have been on sale in the first place, but what of the authors & funders of these articles? What compensation do they get? Their articles weren’t freely available to read for over 2 months – I’d be hopping mad if I was an author of one of those works. I think an appropriate calculation of financial compensation would be the price the article was on sale for, multiplied by the number of days it was wrongly behind a paywall.
Various people, Alicia Wise included, have been telling me that selling access to hybrid OA in this instance was NOT illegal. After a lot of discussion, I think I believe them.
Despite the article being clearly intended to be freely available to readers upon publication by the authors, all parties agree they paid Wiley to make the article freely available, not behind a paywall.
Well, author-publisher contract trickery is the answer, I believe.
Conventional open access publishers simply confirm, via an informed consent process, that the author knows and wants their work to be published typically under the Creative Commons Attribution License (CC-BY). If it gets through the editorial & review process, it is published online solely under the terms of the CC-BY license, and this is clearly marked on the paper. Copyright is fully retained by the authors over their work at all times. It’s a clear one-step process. The publisher AND readers are both bound by the terms of the chosen CC-license.
But Elsevier, Wiley and other merchants of ‘hybrid OA’ do things differently. Typically, they grant themselves carte blanche rights for commercial usage in an author-publisher contract and then afterwards, they publish online the article under a Creative Commons (or other) license. In this case only the readers are bound by the terms of the ‘end-user’ licence – the publisher can to some extent do what they want with impunity.
Needless to say, I think this incident has unveiled a significant flaw / legal loophole in the way that legacy publishers offer ‘hybrid OA’. Authors under these ‘hybrid OA’ systems appear to lose the right to sue their own publisher for wrongful commercial usage of their work.
At the very least I think publishers should print the terms and conditions of the author-publisher contract within each publication itself, so that readers like myself are informed of their ‘special rights’, over-and-above those indicated by the Creative Commons license chosen.
No apologies, no formal statements …so far
I’ve seen a few blog comments here and there from Alicia Wise which has been helpful. It is noted that she has even “thanked” me for raising this issue. I have also been promised a refund for my article purchases.
But thanks is not what I wanted. I didn’t intend to do Elsevier’s system-checking work for them. I want a public apology for this incident, that includes the word ‘sorry':
To myself and others who were wrongly charged for access to ‘open access’ articles
To the authors & research funders of those 27 articles that were paid-for to be made available to readers for free, ‘open access’.
To all the prospective readers, who didn’t get to read those 27 articles for over 2 months because they were behind a paywall.
I accept that these articles were ‘mistakenly’ paywalled, but even when innocent mistakes are made, it is still polite to formally apologise for making them.
For my part, I’m happy to apologise for alleging that these article sales were ‘illegal‘ – it was a logical, justified statement to make at the time, but with hindsight it might not be factually correct. Sorry Elsevier, what you did was not quite ‘illegal’ it was just wrong.
Now I’ve said my public apology for my innocent mistake, perhaps Elsevier could publicly make their apology too?
In March, 2015 ‘hybrid OA’ died after a short-life of neglect. Elsevier put the final nail in the coffin, but it wasn’t just they who were responsible, other publishers were plainly guilty of hybrid OA neglect too.
Publishers gave birth to the cash-cow that was hybrid OA not long ago. The profits were immense: $5000 for a single article in some greedy cases. Yet after each ‘hybrid OA’ article was born, and the profit raked in, the hybrid OA articles were completely neglected post-publication. Much like their shuttered, not-allowed-to-play-outside-the-paywall brothers & sister articles. They were forgotten about, even though their authors had stumped-up significant funds upfront to ensure their freedom forever.
Hybrid OA was a wonderfully profitable system for the publisher/carers. It enabled bountiful double-dipping – additional revenue for providing exactly the same content. Laughably, the publisher/carers claimed that it was “not happening at all“, but anyone with a brain knew better.
But too much neglect of the hybrids over the years led to manyhigh-profile instances of triple-dipping: subscription revenue, APC fees, AND $31.50 (+ tax) per article reader charges (for content that had already been paid to be made free for readers, forever).
A variety of rightlyconcernedfunders started a trend banning authors from sending their articles to hybrid OA profiteer-merchants, for their own good. Only full OA venues could be trusted to actually do the job and the keep the articles outside paywalls.
In short, legacy publishers themselves killed hybrid OA through their own carelessness. Authors, librarians, research funders and readers simply didn’t trust publishers to do hybrid OA properly, and had amassed plenty of evidence of their ineptitude. They tried to sweep the problem of a flawed and difficult system under the carpet as just ‘bumps in the road‘ to open access but actually hybrid OA was just a wrong turn all along.
Elsevier seem to have responded to my criticism yesterday and have stopped selling the article “HIV infection en route to endogenization: two cases” from their ScienceDirect website. Take what you will from that change, but I infer that they have realised that they are in the wrong.
Actually, they are still selling it from the ScienceDirect website too. It only looked freely available to me because I myself had paid for access to it & I guess a cookie remembered me. It’s still on sale at ScienceDirect.com as well as clinicalmicrobiologyandinfection.com
Further update: As of 2015-03-09 17.13 PM the articles were finally freely available ‘unchained'(?) from behind Elsevier’s paywalls.
I couldn’t believe my eyes, so just to make sure they really were still illegally selling this article that shouldn’t be sold, I made another test purchase:
I heard back from Didier (the corresponding author) yesterday. He does not know why Elsevier are selling his article, nor did he give them permission to.
Elsevier (RELX Group) have been doing this for many years now: selling open access articles that authors/funders have paid-for to make freely available to everyone. Peter Murray-Rust, Mike Taylor and others have written about this extensively.
[Update 2015-03-13: I have blogged further about this here and provided a recap here. This post has been viewed over 10,000 times. Clearly some people want to sweep this under the carpet and pretend this is just ‘a storm in a teacup’ but it did happen and people do care about this. Thanks to everyone who spread the word.]
Today, Elsevier (RELX Group) illegally sold me a Creative Commons Attribution-NonCommercial-NoDerivatives licensed article:
Colson, P. et al. HIV infection en route to endogenization: two cases. Clin Microbiol Infect 20, 1280-1288 (2014).
I’m really not happy about it. I don’t think the research funders will be happy about it either. Especially not the authors (who are the copyright holders here).
Below is a screenshot of how the content was illegally on offer for sale, for $31.50 + tax.
To investigate if it really was on sale. I decided to make a test purchase. Just to be absolutely sure. Why not? The abstract looked interesting. The abstract was all I was allowed to read. I wanted to know more.
Below is the email receipt I received confirming my purchase of the content. I have crudely redacted my postal address but it’s otherwise unaltered:
The terms of this widely used license clearly state: “You may not use the material for commercial purposes.”
Wiley respect this license. They make this content freely available on their website here. The authors, or their research funder or institution probably paid Wiley money to make sure that the article could be made freely available to the world.
But tonight, Elsevier were selling it to me and all the world via their ScienceDirect platform.
This is clearly an illegal copyright infringement.
I have tweeted Elsevier employees @wisealic & @TomReller to see how I can get a refund for my purchase at the very least. This article should never have been on sale.
I have also contacted the corresponding author (Didier) to see what his thoughts are.
I do hope the authors will take legal action against Elsevier for their criminal misdeeds here.
My full comments on the PLOS ONE manuscript submission modelling paper:
On 27 January 2015 at 23:05, Chris Woolston <REDACTED> wrote:
Hello again. I contacted you awhile ago for my Nature column on the intersection of science and social media.
Yep I remember.
I’m wondering if I could once more ask for your help. (This is what you get for being a prolific and articulate tweeter.)
Sure why not? Thanks for the compliment
The next edition will look at the PLoS report on the optimum strategy for submitting papers.
Salinas S, Munch SB (2015) Where Should I Send It? Optimizing the Submission Decision Process. PLoS ONE 10(1): e0115451. doi: 10.1371/journal.pone.0115451
A worthy choice. It relates to my most recent research too… I have a preprint in which I comprehensively demonstrate that information published in PLOS ONE is substantially more discoverable than publishing in other paywalled journals – if other researchers can’t discover your paper when searching for relevant terms, they probably won’t cite it…
PLOS ONE is both an open access journal AND a technically excellent content platform, thus it is near perfectly full-text indexed in Google Scholar. Other journals operating a paywall, or with a more simplistic content platform & content provision (e.g. PDF only) are not well indexed in Google Scholar & thus may suffer in terms of citation.
I saw your tweet regarding “scoops.” If you have a moment, I would appreciate a brief elaboration. Isn’t there some extra value in a scoop?
Some academics have an odd psychological complex around this thing called ‘scooping’. The authors of this paper are clearly strong believers in scooping. I don’t believe in scooping myself – it’s a perverse misunderstanding of good scientific practice. I believe what happens is that someone publishes something interesting; useful data testing a novel hypothesis — then somewhere else another academic goes “oh no, I’ve been scooped!” without realising that even if they’re testing exactly the same hypothesis, their data & method is probably different in some or many respects — independently generated and thus extremely useful to science as a replication even if the conclusions from the data are essentially the same.
Many papers are often published, deliberately, testing the same hypothesis on different species, across species, in different countries or habitats, under different conditions – these are not generally labelled ‘already scooped papers’ although under this scheme of thought, perhaps they should be? Particularly in lab or field ecology I find it extremely unlikely that two independent groups could possibly go out and collect data on *exactly* the same hypothesis, species, population, area… They’d bump into one another, surely?
It’s only really with entirely computational theoretical ecology that it might be possible for two independent groups to be working on exactly the same hypothesis, with roughly the same method at the same time. But even here, subtle differences in parameter choice will produce two different experiments & different, independent implementations are useful to validate each other. In short, scooping is a figment of the imagination in my opinion. There should be no shame in being ‘second’ to replicate or experimentally test a hypothesis. All interesting hypotheses should be tested multiple times by independent labs, so REPLICATION IS A GOOD THING.
I suggest the negative psychology around ‘scooping’ in academia has probably arisen in part from the perverse & destructive academic culture of chasing publication in high impact factor journals. Such journals typically will only accept a paper if it is the first to test a particular hypothesis, regardless of the robustness of approach used – hence the nickname ‘glamour publications’ / glam pubs. Worrying about getting scooped is not healthy for science. We should embrace, publish, and value independent replications.
With relevance to the PLOS ONE paper – it’s a fatal flaw in their model that they assumed that ‘scooped’ (replication) papers had negligible value. This is a false assumption. I would like to see an update of calculations where ‘scooped’ (replication) papers are given various parameterizations between 10% & 80% of the value of a completely novel ‘not-scooped’ paper. In such a model I’d expect submitting to journals with efficient, quick submission-to-publication times will be optimal, journals such as PeerJ, F1000Research & PLOS ONE would come top probably. Many academics who initially think they’ve been mildly or partially scooped, rework their paper, do perhaps an additional experiment and then still proceed to publish it. This reality is not reflected in the assumption of “negligible value”.
And don’t scientists generally look for an outlet that will publish their work sooner than later?
Some do. I do. But others chase high impact factor publication & glamour publication – this is silly, and in many cases results in a high-risk suboptimal strategy. I know people who essentially had to quit academia because they chose this high-risk approach (and failed / didn’t get lucky) rather than just publishing their work in decent outlets that do the job appropriately.
I suppose that’s a big part of the decision process: Impact vs. expediency. Did any of the other points in the paper strike your attention?
It’s great news for PLOS ONE. Many ecologists have a strange & irrational distaste for PLOS ONE, particularly in the UK – often it’s partly a reticence around open access but also many seem to wilfully misunderstand PLOS ONE’s review process: reviewing for scientific-soundness and not perceived potential ‘impact’. This paper provides solid evidence that if you want your work to be cited, PLOS ONE is great place to send your work.
Citations aren’t the be all & and all though. It’s dangerous to encourage publication strategies based purely on maximising number of citations. Such thinking encourages sensationalism & ‘link-bait’ article titles, at a cost to robust science. To be highly-cited is NOT the purpose of publishing research. Brilliant research that saves lives, reduces global warming, or some other real-world concrete impact, can have a fairly low absolute number of citations. Likewise research in a popular field or topic can be highly-cited simply because many people are also publishing in that area. Citations don’t necessarily equate to good scholarship or ‘worthyness’.
I would welcome a brief response over email, or perhaps we could schedule a chat on the phone tomorrow. I’m in the US, and I’m generally not available before 3 p.m. your time. Thank you.
I’ll skip the phone chat if that’s okay. I’ve failed to be brief but I’ve bolded bits I think are key.